|
|
§ 15-801 |
Benefits for Alzheimer’s disease and care of elderly individuals |
§ 15-802 |
Benefits for treatment of mental illnesses, emotional disorders, and drug and alcohol misuse |
§ 15-803 |
Payments for blood products |
§ 15-804 |
Coverage for off-label use of drugs |
§ 15-805 |
Reimbursement for pharmaceutical products |
§ 15-806 |
Choice of pharmacy for filling prescriptions |
§ 15-807 |
Coverage for medical foods and modified food products |
§ 15-808 |
Benefits for home health care |
§ 15-809 |
Benefits for hospice care services |
§ 15-810 |
Benefits for in vitro fertilization |
§ 15-810.1 |
Coverage for standard fertility preservation procedures |
§ 15-811 |
Hospitalization benefits for childbirth |
§ 15-812 |
Inpatient hospitalization coverage for mothers and newborn children |
§ 15-813 |
Benefits for disability caused by pregnancy or childbirth |
§ 15-814 |
Coverage for breast cancer screenings |
§ 15-814.1 |
Copayments for diagnostic breast examination |
§ 15-815 |
Coverage for reconstructive breast surgery |
§ 15-816 |
Benefits for routine gynecological care |
§ 15-817 |
Coverage for child wellness services |
§ 15-818 |
Benefits for treatment of cleft lip and cleft palate |
§ 15-819 |
Coverage for outpatient services and second opinions |
§ 15-820 |
Benefits for orthopedic braces |
§ 15-821 |
Diagnostic and surgical procedures for bones of face, neck, and head |
§ 15-822 |
Coverage for diabetes equipment, supplies, and self-management training |
§ 15-822.1 |
Limited copayments |
§ 15-823 |
Coverage for osteoporosis prevention and treatment |
§ 15-824 |
Coverage for maintenance drugs |
§ 15-825 |
Coverage for detection of prostate cancer |
§ 15-826 |
Coverage for prescription drugs |
§ 15-826.1 |
Coverage for contraceptive drugs and devices |
§ 15-826.2 |
Coverage for male sterilization (§ 15-826.2) |
§ 15-826.3 |
Coverage for fertility awareness-based methods |
§ 15-827 |
Coverage for patient cost for clinical trials |
§ 15-828 |
Coverage for charges related to dental care |
§ 15-829 |
Coverage for detection of chlamydia |
§ 15-830 |
Referrals to specialists |
§ 15-830 v2 |
Referrals to specialists |
§ 15-831 |
Coverage of prescription drugs |
§ 15-832 |
Coverage for removal of testicle |
§ 15-832.1 |
Inpatient hospitalization coverage following mastectomy |
§ 15-833 |
Extension of benefits |
§ 15-834 |
Coverage for prostheses |
§ 15-835 |
Required coverage for habilitative services |
§ 15-836 |
Hair prosthesis |
§ 15-837 |
Colorectal cancer screening coverage |
§ 15-838 |
Hearing aid coverage for a minor child |
§ 15-839 |
Coverage for treatment of morbid obesity |
§ 15-840 |
Coverage for medically necessary residential crisis services |
§ 15-841 |
Coverage for smoking cessation treatment |
§ 15-842 |
Copayment or coinsurance for prescription drugs and devices limited |
§ 15-843 |
Coverage for amino acid-based elemental formula |
§ 15-844 |
Benefits for prosthetic devices |
§ 15-845 |
Coverage for refills of prescription eye drops |
§ 15-846 |
Coverage for cancer chemotherapy |
§ 15-847 |
Coverage for specialty drugs |
§ 15-847.1 |
Limit on copayment or coinsurance requirement on a prescription drug prescribed to treat diabetes, HIV, or AIDS |
§ 15-848 |
Coverage for ostomy equipment and supplies |
§ 15-849 |
Coverage for abuse-deterrent opioid analgesic drug products |
§ 15-850 |
Prior authorizations for opioid antagonist |
§ 15-851 |
Prior authorization for drug products to treat opioid use disorder – Prohibition |
§ 15-852 |
Prorated daily copayment or coinsurance amount for partial supply of prescription drug |
§ 15-853 |
Gradient compression garment |
§ 15-854 |
Prior authorization for prescription drug |
§ 15-854 v2 |
Prior authorization for prescription drug |
§ 15-855 |
Coverage for diagnosis, evaluation, and treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome |
§ 15-856 |
Coverage for COVID-19 tests |
§ 15-857 |
Coverage for COVID-19 tests |
§ 15-858 |
Prior authorization requirement for a prescription drug used as postexposure prophylaxis for the prevention of HIV |
§ 15-859 |
Coverage for recommended follow-up diagnostic imaging to assist in the diagnosis of lung cancer |
§ 15-860 |
Biomarker testing |